Skip to main content

BMEZ · BlackRock Health Sciences Term Trust

Track BMEZ — free
$15.92 -0.50 (-3.05%) At close · Nov 19
Market Cap
$995.02M
Shares
62.50M
Volume · Nov 19 211.54K Avg daily vol (3M) 158.97K

Price & Indicators

 

Key stats

Close
$15.92
Open
$16.26
Day range
$15.88–16.69
52-week closing range
$13.76–17.85
Average volume, 30 days
176K
Short interest
87K · 0.1% of shares · 1.0 days
Short volume, last session
38%
Price history
Jan 2020 to Nov 2026

Latest documents

2026
Nov 19
Tender offer SC TO-I/A
Tender Offer Oversubscribed With 13,178,845 Shares Tendered

BlackRock Health Sciences Term Trust's tender offer expired November 18, 2026, with 13,178,845 shares tendered against 3,125,070 sought. Because it was oversubscribed, purchases will be prorated at 98% of net asset value.

4 source passages
The Tender Offer commenced on October 16, 2026 and expired at 5:00 p.m. Eastern time on November 18, 2026. 3,125,070 | | | 13,178,845 Based on the preliminary results shown above, because the Tender Offer was oversubscribed for the Fund, the relative number of Shares that will be purchased from each shareholder is expected to be prorated based on the number of Shares properly tendered for the Fund. The purchase price of properly tendered and accepted Shares for the Fund will be 98% of the Fund’s net asset value (“NAV”) as of the close of regular trading on the New York Stock Exchange on November 19, 2026, the business day immediately following the expiration date of the Tender Offer. Open the document at this passage
Oct 16
Tender offer SC TO-I
Tender offer

BlackRock Health Sciences Term Trust will repurchase up to 5% of its shares for cash at 98% of NAV per share. The tender offer expires at 5:00 P.M., Eastern Time, on November 18, 2026, unless extended.

Read from the first part of this long document
Oct 1
Tender offer SC TO-C
Tender offer

BlackRock Health Sciences Term Trust will conduct a tender offer for up to 5% of outstanding common shares at 98% of NAV per share. The offer is scheduled from October 16, 2026 to November 18, 2026.

Jun 2
Proxy statement DEF 14A Meeting Jul 22, 2026
Proxy statement AI summary on its way
2025
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
8.3%
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+8.8%
Trailing year
Short interest
0.1%
Latest settlement · 1.0 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Neutral Momentum Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very Low
Market backdrop VIX 28.4 · fear Equity put/call 0.72
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +3%
above
Price vs 50-day avg −5%
below
RSI (14) 32
neutral
MACD trend Negative
52-week position 53%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return −5%
trailing
6-month return +9%
trailing
YTD return +6%
this year
Relative strength +15%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $17 › 200d $15 — 50d above 200d
Institutional flow Flat
0% holders QoQ · +10 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.14% of shares out · ▲ +82.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
89 holders — mid 3-yr range
Squeeze score 43
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very Low
Volatility 18%
annualized · 1-yr
Max drawdown −13%
past year
ATR 2.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+3% Bullish
Price vs 50-day avg
−5% Bearish
RSI (14)
32 Neutral
MACD trend
Negative Bearish
52-week position
53% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $17 › 200d $15 — 50d above 200d
Institutional flow Flat
0% holders QoQ · +10 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.14% of shares out · ▲ +82.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
89 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $14 Now $16 · 53% Range high $18
vs 200-day avg +3% vs 50-day avg -5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Asset Management — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BMEZ
BlackRock Health Sciences Term Trust
this stock
$995.02M +5.8% — — 0.1%
BLK
BlackRock, Inc.
$184.04B +6.1% +16.2% 25.9 1.3%
BX
Blackstone Inc.
$87.12B -24.8% +9.2% 25.8 2.6%
BN
BROOKFIELD Corp
$86.68B -15.1% — — 1.0%
KKR
KKR & Co. Inc.
$82.19B -27.7% -11.0% — 1.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
89
% held
28.4%
Net QoQ
+1.0M sh
Top holder
MORGAN STANLEY
Held Float
View
Held by Funds
Fund positions
9
View
Short & Settlement
Short Interest Rising
Shares short
87.5K
Days to cover
1.0d
Change
+39.5K sh
View
Short Volume
Short vol %
38%
As of
Nov 19, 2026
Short Total
View
Fails to Deliver
FTD shares
1.2K
Value
$21.0K
As of
Oct 27, 2026
View
Off-Exchange
Off-exchange %
60.8%
Week of
Oct 12, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
SC TO-I/A
Filed
Nov 19, 2026
This year
4

BlackRock Health Sciences Term Trust's tender offer expired November 18, 2026, with 13,178,845 shares tendered against 3,125,070 sought. Because it was oversubscribed, purchases will be prorated at 98% of net asset value.

View

Performance

5D 20D 120D MTD YTD
BMEZ -7.9% -5.1% +9.3% -9.3% +5.8%
SPY -5.5% -6.3% -5.6% -5.3% +5.0%
vs SPY -2.5% +1.2% +15.0% -4.1% +0.8%

Capital returns

Latest dividend
$0.11 / share · ex Nov 13, 2026
Declared · upcoming
$0.11 / share · ex Dec 11, 2026
Cut 32.5%
Paid (TTM)
$1.32 / share · 12 payouts
Dividend yield (TTM, derived)
8.29%
Full dividend history

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1785971 CUSIP 09260E105 13F (30d) 99 filings 83 filers